MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Earnings History & Surprises
NASDAQ:MLTX • KY61559X1045
18.15 USD
+0.13 (+0.72%)
At close: Mar 6, 2026
18.0096 USD
-0.14 (-0.77%)
After Hours: 3/6/2026, 8:00:02 PM
Past quarterly earnings results for MOONLAKE IMMUNOTHERAPEUTICS (MLTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.92
Revenue Estimate
Last Reported
Release DateJan 8, 2026
PeriodQ4 / 2025
EPS Reported-$0.92
EPS Surprise 9.02%
Revenue Surprise %
Beat Rate
13%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.92 | -1.01 | 9.02% | -27.50% | - | - | ||
| Q3 2025 | -1.10 | -0.90 | -22.75% | -96.43% | - | - | ||
| Q2 2025 | -0.87 | -0.74 | -18.26% | -123.08% | - | - | ||
| Q1 2025 | -0.63 | -0.77 | 17.89% | -186.36% | - | - | ||
| Q4 2024 | -0.72 | -0.61 | -18.11% | -500.00% | - | - | ||
| Q3 2024 | -0.56 | -0.44 | -26.10% | -211.11% | - | - | ||
| Q2 2024 | -0.39 | -0.28 | -37.92% | -69.57% | - | - | ||
| Q1 2024 | -0.22 | -0.20 | -11.55% | 4.35% | - | - | ||
| Q4 2023 | -0.12 | -0.23 | 48.88% | 61.29% | - | - | ||
| Q3 2023 | -0.18 | -0.23 | 22.46% | 33.33% | - | - | ||
| Q2 2023 | -0.23 | -0.27 | 15.13% | 32.35% | - | - | ||
| Q1 2023 | -0.23 | -0.32 | 27.32% | - | - | - | ||
| Q4 2022 | -0.31 | -0.33 | 7.18% | - | - | - | ||
| Q3 2022 | -0.27 | -0.33 | 17.45% | - | - | - | ||
| Q2 2022 | -0.34 | -0.55 | 38.27% | - | - | - | ||
| Q1 2022 | - | - | - | - | ||||
| Q4 2021 | - | - | - | - | ||||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-3.52%
Max EPS beat (4)
17.89%
Min EPS beat (4)
-22.75%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, MLTX has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, MLTX reported -3.5% below the EPS estimates on average.
MOONLAKE IMMUNOTHERAPEUTICS / MLTX Earnings FAQ
Can you provide the last earnings date for MOONLAKE IMMUNOTHERAPEUTICS?
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) last reported earnings on 1/8/2026.
Can you provide information on whether MOONLAKE IMMUNOTHERAPEUTICS beat earnings estimates in the last quarter?
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does MOONLAKE IMMUNOTHERAPEUTICS (MLTX) beat earnings estimates?
In the last 4 quarters, MOONLAKE IMMUNOTHERAPEUTICS (MLTX) has beaten EPS estimates in 2 out of 4 releases.